Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
MARINUS PHARMACEUTICALS, INC.
| Metric | MARINUS PHARMACEUTICALS, INC. MRNSHealthcare |
|---|---|
| Quality Score | 57 / 100 |
| Revenue (latest) | $31M |
| Net income (latest) | −$141M |
| Operating margin | −424.3% |
| Net margin | −456.3% |
| Return on equity | −843.5% |
| Return on assets | −82.7% |
| Return on capital (ROCE) | −100.9% |
| Debt / equity | 9.19× |
| Revenue growth (YoY) | 21.6% |
| Altman Z″ (distress) | -11.18 |
| Accruals / assets | −13.7% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.